Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA approves Leukine for H-ARS

April 3, 2018

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

FDA advisory committee recommends approval of Lucemyra

March 28, 2018

Novel metabotropic glutamate mGlu7 receptor agonists synthesized at Takeda

March 28, 2018

Soligenix receives E.U. orphan designation for RiVax

March 23, 2018

Institute of Radiation Medicine presents novel compounds protecting against radiation

March 19, 2018

Japanese researchers disclose PDE7 inhibitors

March 15, 2018

University of Bristol presents new alpha4beta2 nicotinic receptor partial agonists

March 8, 2018

Anti-heroin vaccine demonstrates efficacy in rodents

March 7, 2018

Sublocade becomes available as first and only monthly injectable buprenorphine in the U.S.

March 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...